241-255 of 2842

Reconnecting With Patients: A Human-Centered Approach to Everyday Practice
Clinician's RoundtableReconnecting With Patients: A Human-Centered Approach to Everyday Practice

"I think we're the bridge between the healthcare systems, the pharma systems, and the molecular diagnostic systems," says Matt Newman with Manifold
The Convergence"I think we're the bridge between the healthcare systems, the pharma systems, and the molecular diagnostic systems," says Matt Newman with Manifold

Negative Symptoms in Schizophrenia: Identifying and Managing the Hidden Burden
On the Frontlines of SchizophreniaNegative Symptoms in Schizophrenia: Identifying and Managing the Hidden Burden

Using fMRI to Identify Early Alzheimer’s Disease Subgroups
NeuroFrontiersUsing fMRI to Identify Early Alzheimer’s Disease Subgroups

Evaluating AR1001: A Phase 3 Trial in Early Alzheimer’s Disease
NeuroFrontiersEvaluating AR1001: A Phase 3 Trial in Early Alzheimer’s Disease

Advances in Colorectal Cancer Detection: Exploring the Role of Blood-Based Tests
GI InsightsAdvances in Colorectal Cancer Detection: Exploring the Role of Blood-Based Tests
- advertisement

Stories in PNH: Case Experiences from the Clinic
Project Oncology®Stories in PNH: Case Experiences from the Clinic

Understanding the Role of the Alternate Complement Pathway in PNH
Project Oncology®Understanding the Role of the Alternate Complement Pathway in PNH

Recognizing the Burden of Paroxysmal Nocturnal Hemoglobinuria
Project Oncology®Recognizing the Burden of Paroxysmal Nocturnal Hemoglobinuria

Examining Unmet Needs in Paroxysmal Nocturnal Hemoglobinuria
Project Oncology®Examining Unmet Needs in Paroxysmal Nocturnal Hemoglobinuria
- advertisement

Next-Gen Clinical Monitoring: Predicting Inpatient Decline with AI-Driven Alerts
The ConvergenceNext-Gen Clinical Monitoring: Predicting Inpatient Decline with AI-Driven Alerts

Evaluating Sabirnetug in Early Alzheimer’s: Targeting Soluble Aβ Oligomers
NeuroFrontiersEvaluating Sabirnetug in Early Alzheimer’s: Targeting Soluble Aβ Oligomers

Individualized Cognitive Stimulation in Mild Alzheimer’s Disease: Evidence from a Multicenter RCT
NeuroFrontiersIndividualized Cognitive Stimulation in Mild Alzheimer’s Disease: Evidence from a Multicenter RCT
















































